It was found that simultaneous blockade of PP2A and PD1 significantly improved OS in GBM mice, with a substantial increase in the number of immunoreactive T cells in the group compared to the control group, and resulted in complete regression of GBM in about a quarter of the mice. This evidence concerns the gene PTPA and glioblastoma.